The European Chemicals Agency (ECHA) is seeking comments on 19 applications for authorisation covering 30 uses of:
- 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (EC-, CAS-); and
- 4-nonylphenol, branched and linear, ethoxylated (EC-, CAS-).
The substances are used in the production of various medical devices (e.g. in vitro diagnostic kits and reagents) and medicinal, biopharmaceuticals and laboratory products (e.g. active pharmaceutical ingredients); also used in the manufacture of interlayer polymer films for laminated safety glass. Further information about the uses that authorisation is applied for, including the description of the function of the substance, exposure scenarios, possible alternatives identified by the applicants, together with socio-economic information, is available on ECHA’s website. The deadline for comments is 8 January 2020.
ECHA News, 13 November 2019